Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Vitamin K Market
Vitamin K Market Share
- Report ID: GMI1481
- Published Date: May 2023
- Report Format: PDF
Vitamin K Market Share
Some of the leading vitamin K market contenders are
- NattoPharma ASA
- BASF SE
- Country Life,LLC (Kikkoman Corporation)
- Pfizer Inc.
- Amphastar Pharmaceuticals Inc.
- DSM
- Kappa Bioscience
- Livealth Biopharma Pvt. Ltd.
- NOW Foods
- Solgar Inc.
These firms are working on product approvals, acquisitions and several other strategies to sustain the rising competition.
Frequently Asked Questions (FAQ) :
Global market for vitamin K reached USD 839 million in 2022 and is estimated to witness 8.7% CAGR from 2023-2032 due to the growing burden of chronic diseases, such as diabetes, arthritis, and cardiovascular diseases worldwide.
Vitamin K1 segment will observe 8.2% CAGR from 2023-2032 owing to the growing popularity of diet supplements.
North America vitamin K market will reach over USD 858 million by 2032 owing to the surging prevalence of chronic diseases and coagulation disorders.
NattoPharma ASA, BASF SE, Country Life, LLC (Kikkoman Corporation), Pfizer Inc., Amphastar Pharmaceuticals Inc., DSM, Kappa Bioscience, Livealth Biopharma Pvt. Ltd., NOW Foods, and Solgar Inc. are some of the renowned vitamin K industry players.
Vitamin K Market Scope
×
Get a free sample of
Vitamin K Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below